Professor Steve Kerrigan from RCSI School of Pharmacy and Biomolecular Sciences has been researching #sepsis for 25 years. In this piece for #WorldSepsisDay he speaks to RTÉ News about raising awareness of the illness and how it is caused. ⬇️ rte.ie/news/health/20…

On this #WorldSepsisDay it's important that the government now funds the 5-year Sepsis Strategic Action Plan in Ireland.

Inthelia are thrilled to be announced as one of the awardees for the #BLUEKNIGHT #QuickFireChallenge. Looking ahead with great anticipation to continue innovating for a better and safer future.

The 40th Congress of the ESS is just starting with the Summer School and the ESS Board Meeting in the historical buildings of the University of Vienna

Delighted to be attending @scienceirel summit 2023. Looking forward to many interesting conversations and discussions about the high impact of scientific research in Ireland. RCSI School of Pharmacy and Biomolecular Sciences RCSI RCSI Research and Innovation

Very proud moment....

RCSI spin-out Inthelia Therapeutics founded by Prof Steve Kerrigan RCSI School of Pharmacy and Biomolecular Sciences features in today's The Irish Times. Read how Inthelia Therapeutics is taking a new approach to tackling #sepsis, which accounts for half of all hospital fatalities ➡️ irishtimes.com/business/innov… #RCSIdiscover

Fantastic new innovative and interactive website, well done RCSI School of Pharmacy and Biomolecular Sciences spin out company #inthelia it looks fantastic. RCSI RCSI School of Pharmacy and Biomolecular Sciences Enterprise Ireland RCSI Research and Innovation

Thrilled to be announced as the winner of the Investnet Future Health Summit 2024 Innovation Award, sponsored by UPMC. RCSI RCSI Research and Innovation RCSI School of Pharmacy and Biomolecular Sciences

Know the signs and symptoms of sepsis, if it doesn't feel right it probably isn't ... RCSI RCSI Research and Innovation RCSI School of Pharmacy and Biomolecular Sciences Sepsis: why this deadly condition is so hard to diagnose theconversation.com/sepsis-why-thi… via The Conversation

Steve Kerrigan shares our programme for the day on behalf of the #AIPC2024 organising committee RCSI - anticipating guest speakers from across Ireland. Take a look at the link below for the impressive abstract list! 🔗 rcsi.com/dublin/-/media…

Later, we'll be joined by our own Michelle Kirrane Scott & Adam Lee for an informal fireside chat in the Garden Lounge - sharing experiences of navigating diverse pharmacy careers now & in the future 💊🌍 Join the conversation! #AIPC2024

Come on Ireland #COYBIG

Come on Ireland (again) #COYBIG

We are now on LinkedIn! Use the link below to follow us for more detailed summaries of news, research, education and events as we continue our growth. linkedin.com/company/rcsi-s…

An article in today's The Irish Times reports the growth in home-grown pharmaceutical innovation & start-ups. This features Steve Kerrigan discussing Inthelia Therapeutics & the opportunities of new degree programmes inc. our BSc in Advanced Therapeutic Technologies. irishtimes.com/special-report…

Our growing understanding of how bacteria and inflammation travel across systems is changing the way we think about prevention. Thank you to The Conversation for helping amplify this critical message. #endocarditis #sepsis

Many people now survive #sepsis, but they can be left with lasting cognitive, physical and psychological challenges. Professor Steve Kerrigan writes in The Conversation on the long-term effects of post-sepsis syndrome. ➡️ theconversation.com/post-sepsis-sy… RCSI School of Pharmacy and Biomolecular Sciences

Join Steve Kerrigan as part of the #PintofScience programme to learn about #sepsis & build awareness of the #warningsigns that could save lives. Steve will be joined by both a sepsis survivor & a family member of an individual who sadly died suddenly from sepsis.

m.independent.ie/irish-news/hea… RCSI School of Pharmacy and Biomolecular Sciences RCSI @rcsi